Medical Care
Global Chronic Lung Diseases Treatment Market Research Report 2024
- Jan 20, 24
- ID: 17817
- Pages: 82
- Figures: 160
- Views: 46
Lung disease is a very common medical condition that is present in almost every region of the world. Chronic lung diseases can be dangerous and if not treated properly can cause death. The chronic lung diseases cause uneasiness and complications in the respiratory system thus causing difficulty in respiration.
The global Chronic Lung Diseases Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Chronic Lung Diseases Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Lung Diseases Treatment.
Report Scope
The Chronic Lung Diseases Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chronic Lung Diseases Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chronic Lung Diseases Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boehringer Ingelheim
Novartis
Roche
Astellas Pharma
Dr. Reddy’s Laboratories
GlaxoSmithKline
AstraZeneca
Sanofi
Teva Pharmaceuticals
Asmacure Ltée
Segment by Type
Injection
Capsule
Tablet
Other
Segment by Application
Bronchopulmonary Dysplasia
Asthma
COPD
Pulmonary Fibrosis
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chronic Lung Diseases Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Chronic Lung Diseases Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Chronic Lung Diseases Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Lung Diseases Treatment.
Report Scope
The Chronic Lung Diseases Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chronic Lung Diseases Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chronic Lung Diseases Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boehringer Ingelheim
Novartis
Roche
Astellas Pharma
Dr. Reddy’s Laboratories
GlaxoSmithKline
AstraZeneca
Sanofi
Teva Pharmaceuticals
Asmacure Ltée
Segment by Type
Injection
Capsule
Tablet
Other
Segment by Application
Bronchopulmonary Dysplasia
Asthma
COPD
Pulmonary Fibrosis
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chronic Lung Diseases Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chronic Lung Diseases Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Injection
1.2.3 Capsule
1.2.4 Tablet
1.2.5 Other
1.3 Market by Application
1.3.1 Global Chronic Lung Diseases Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Bronchopulmonary Dysplasia
1.3.3 Asthma
1.3.4 COPD
1.3.5 Pulmonary Fibrosis
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chronic Lung Diseases Treatment Market Perspective (2019-2030)
2.2 Chronic Lung Diseases Treatment Growth Trends by Region
2.2.1 Global Chronic Lung Diseases Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Chronic Lung Diseases Treatment Historic Market Size by Region (2019-2024)
2.2.3 Chronic Lung Diseases Treatment Forecasted Market Size by Region (2025-2030)
2.3 Chronic Lung Diseases Treatment Market Dynamics
2.3.1 Chronic Lung Diseases Treatment Industry Trends
2.3.2 Chronic Lung Diseases Treatment Market Drivers
2.3.3 Chronic Lung Diseases Treatment Market Challenges
2.3.4 Chronic Lung Diseases Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chronic Lung Diseases Treatment Players by Revenue
3.1.1 Global Top Chronic Lung Diseases Treatment Players by Revenue (2019-2024)
3.1.2 Global Chronic Lung Diseases Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Chronic Lung Diseases Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Chronic Lung Diseases Treatment Revenue
3.4 Global Chronic Lung Diseases Treatment Market Concentration Ratio
3.4.1 Global Chronic Lung Diseases Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chronic Lung Diseases Treatment Revenue in 2023
3.5 Chronic Lung Diseases Treatment Key Players Head office and Area Served
3.6 Key Players Chronic Lung Diseases Treatment Product Solution and Service
3.7 Date of Enter into Chronic Lung Diseases Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Chronic Lung Diseases Treatment Breakdown Data by Type
4.1 Global Chronic Lung Diseases Treatment Historic Market Size by Type (2019-2024)
4.2 Global Chronic Lung Diseases Treatment Forecasted Market Size by Type (2025-2030)
5 Chronic Lung Diseases Treatment Breakdown Data by Application
5.1 Global Chronic Lung Diseases Treatment Historic Market Size by Application (2019-2024)
5.2 Global Chronic Lung Diseases Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Chronic Lung Diseases Treatment Market Size (2019-2030)
6.2 North America Chronic Lung Diseases Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Chronic Lung Diseases Treatment Market Size by Country (2019-2024)
6.4 North America Chronic Lung Diseases Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Chronic Lung Diseases Treatment Market Size (2019-2030)
7.2 Europe Chronic Lung Diseases Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Chronic Lung Diseases Treatment Market Size by Country (2019-2024)
7.4 Europe Chronic Lung Diseases Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chronic Lung Diseases Treatment Market Size (2019-2030)
8.2 Asia-Pacific Chronic Lung Diseases Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Chronic Lung Diseases Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Chronic Lung Diseases Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Chronic Lung Diseases Treatment Market Size (2019-2030)
9.2 Latin America Chronic Lung Diseases Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Chronic Lung Diseases Treatment Market Size by Country (2019-2024)
9.4 Latin America Chronic Lung Diseases Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chronic Lung Diseases Treatment Market Size (2019-2030)
10.2 Middle East & Africa Chronic Lung Diseases Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Chronic Lung Diseases Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Chronic Lung Diseases Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Detail
11.1.2 Boehringer Ingelheim Business Overview
11.1.3 Boehringer Ingelheim Chronic Lung Diseases Treatment Introduction
11.1.4 Boehringer Ingelheim Revenue in Chronic Lung Diseases Treatment Business (2019-2024)
11.1.5 Boehringer Ingelheim Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Chronic Lung Diseases Treatment Introduction
11.2.4 Novartis Revenue in Chronic Lung Diseases Treatment Business (2019-2024)
11.2.5 Novartis Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Chronic Lung Diseases Treatment Introduction
11.3.4 Roche Revenue in Chronic Lung Diseases Treatment Business (2019-2024)
11.3.5 Roche Recent Development
11.4 Astellas Pharma
11.4.1 Astellas Pharma Company Detail
11.4.2 Astellas Pharma Business Overview
11.4.3 Astellas Pharma Chronic Lung Diseases Treatment Introduction
11.4.4 Astellas Pharma Revenue in Chronic Lung Diseases Treatment Business (2019-2024)
11.4.5 Astellas Pharma Recent Development
11.5 Dr. Reddy’s Laboratories
11.5.1 Dr. Reddy’s Laboratories Company Detail
11.5.2 Dr. Reddy’s Laboratories Business Overview
11.5.3 Dr. Reddy’s Laboratories Chronic Lung Diseases Treatment Introduction
11.5.4 Dr. Reddy’s Laboratories Revenue in Chronic Lung Diseases Treatment Business (2019-2024)
11.5.5 Dr. Reddy’s Laboratories Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Detail
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Chronic Lung Diseases Treatment Introduction
11.6.4 GlaxoSmithKline Revenue in Chronic Lung Diseases Treatment Business (2019-2024)
11.6.5 GlaxoSmithKline Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Detail
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Chronic Lung Diseases Treatment Introduction
11.7.4 AstraZeneca Revenue in Chronic Lung Diseases Treatment Business (2019-2024)
11.7.5 AstraZeneca Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Detail
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Chronic Lung Diseases Treatment Introduction
11.8.4 Sanofi Revenue in Chronic Lung Diseases Treatment Business (2019-2024)
11.8.5 Sanofi Recent Development
11.9 Teva Pharmaceuticals
11.9.1 Teva Pharmaceuticals Company Detail
11.9.2 Teva Pharmaceuticals Business Overview
11.9.3 Teva Pharmaceuticals Chronic Lung Diseases Treatment Introduction
11.9.4 Teva Pharmaceuticals Revenue in Chronic Lung Diseases Treatment Business (2019-2024)
11.9.5 Teva Pharmaceuticals Recent Development
11.10 Asmacure Ltée
11.10.1 Asmacure Ltée Company Detail
11.10.2 Asmacure Ltée Business Overview
11.10.3 Asmacure Ltée Chronic Lung Diseases Treatment Introduction
11.10.4 Asmacure Ltée Revenue in Chronic Lung Diseases Treatment Business (2019-2024)
11.10.5 Asmacure Ltée Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chronic Lung Diseases Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Injection
1.2.3 Capsule
1.2.4 Tablet
1.2.5 Other
1.3 Market by Application
1.3.1 Global Chronic Lung Diseases Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Bronchopulmonary Dysplasia
1.3.3 Asthma
1.3.4 COPD
1.3.5 Pulmonary Fibrosis
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chronic Lung Diseases Treatment Market Perspective (2019-2030)
2.2 Chronic Lung Diseases Treatment Growth Trends by Region
2.2.1 Global Chronic Lung Diseases Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Chronic Lung Diseases Treatment Historic Market Size by Region (2019-2024)
2.2.3 Chronic Lung Diseases Treatment Forecasted Market Size by Region (2025-2030)
2.3 Chronic Lung Diseases Treatment Market Dynamics
2.3.1 Chronic Lung Diseases Treatment Industry Trends
2.3.2 Chronic Lung Diseases Treatment Market Drivers
2.3.3 Chronic Lung Diseases Treatment Market Challenges
2.3.4 Chronic Lung Diseases Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chronic Lung Diseases Treatment Players by Revenue
3.1.1 Global Top Chronic Lung Diseases Treatment Players by Revenue (2019-2024)
3.1.2 Global Chronic Lung Diseases Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Chronic Lung Diseases Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Chronic Lung Diseases Treatment Revenue
3.4 Global Chronic Lung Diseases Treatment Market Concentration Ratio
3.4.1 Global Chronic Lung Diseases Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chronic Lung Diseases Treatment Revenue in 2023
3.5 Chronic Lung Diseases Treatment Key Players Head office and Area Served
3.6 Key Players Chronic Lung Diseases Treatment Product Solution and Service
3.7 Date of Enter into Chronic Lung Diseases Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Chronic Lung Diseases Treatment Breakdown Data by Type
4.1 Global Chronic Lung Diseases Treatment Historic Market Size by Type (2019-2024)
4.2 Global Chronic Lung Diseases Treatment Forecasted Market Size by Type (2025-2030)
5 Chronic Lung Diseases Treatment Breakdown Data by Application
5.1 Global Chronic Lung Diseases Treatment Historic Market Size by Application (2019-2024)
5.2 Global Chronic Lung Diseases Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Chronic Lung Diseases Treatment Market Size (2019-2030)
6.2 North America Chronic Lung Diseases Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Chronic Lung Diseases Treatment Market Size by Country (2019-2024)
6.4 North America Chronic Lung Diseases Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Chronic Lung Diseases Treatment Market Size (2019-2030)
7.2 Europe Chronic Lung Diseases Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Chronic Lung Diseases Treatment Market Size by Country (2019-2024)
7.4 Europe Chronic Lung Diseases Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chronic Lung Diseases Treatment Market Size (2019-2030)
8.2 Asia-Pacific Chronic Lung Diseases Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Chronic Lung Diseases Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Chronic Lung Diseases Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Chronic Lung Diseases Treatment Market Size (2019-2030)
9.2 Latin America Chronic Lung Diseases Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Chronic Lung Diseases Treatment Market Size by Country (2019-2024)
9.4 Latin America Chronic Lung Diseases Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chronic Lung Diseases Treatment Market Size (2019-2030)
10.2 Middle East & Africa Chronic Lung Diseases Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Chronic Lung Diseases Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Chronic Lung Diseases Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Detail
11.1.2 Boehringer Ingelheim Business Overview
11.1.3 Boehringer Ingelheim Chronic Lung Diseases Treatment Introduction
11.1.4 Boehringer Ingelheim Revenue in Chronic Lung Diseases Treatment Business (2019-2024)
11.1.5 Boehringer Ingelheim Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Chronic Lung Diseases Treatment Introduction
11.2.4 Novartis Revenue in Chronic Lung Diseases Treatment Business (2019-2024)
11.2.5 Novartis Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Chronic Lung Diseases Treatment Introduction
11.3.4 Roche Revenue in Chronic Lung Diseases Treatment Business (2019-2024)
11.3.5 Roche Recent Development
11.4 Astellas Pharma
11.4.1 Astellas Pharma Company Detail
11.4.2 Astellas Pharma Business Overview
11.4.3 Astellas Pharma Chronic Lung Diseases Treatment Introduction
11.4.4 Astellas Pharma Revenue in Chronic Lung Diseases Treatment Business (2019-2024)
11.4.5 Astellas Pharma Recent Development
11.5 Dr. Reddy’s Laboratories
11.5.1 Dr. Reddy’s Laboratories Company Detail
11.5.2 Dr. Reddy’s Laboratories Business Overview
11.5.3 Dr. Reddy’s Laboratories Chronic Lung Diseases Treatment Introduction
11.5.4 Dr. Reddy’s Laboratories Revenue in Chronic Lung Diseases Treatment Business (2019-2024)
11.5.5 Dr. Reddy’s Laboratories Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Detail
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Chronic Lung Diseases Treatment Introduction
11.6.4 GlaxoSmithKline Revenue in Chronic Lung Diseases Treatment Business (2019-2024)
11.6.5 GlaxoSmithKline Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Detail
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Chronic Lung Diseases Treatment Introduction
11.7.4 AstraZeneca Revenue in Chronic Lung Diseases Treatment Business (2019-2024)
11.7.5 AstraZeneca Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Detail
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Chronic Lung Diseases Treatment Introduction
11.8.4 Sanofi Revenue in Chronic Lung Diseases Treatment Business (2019-2024)
11.8.5 Sanofi Recent Development
11.9 Teva Pharmaceuticals
11.9.1 Teva Pharmaceuticals Company Detail
11.9.2 Teva Pharmaceuticals Business Overview
11.9.3 Teva Pharmaceuticals Chronic Lung Diseases Treatment Introduction
11.9.4 Teva Pharmaceuticals Revenue in Chronic Lung Diseases Treatment Business (2019-2024)
11.9.5 Teva Pharmaceuticals Recent Development
11.10 Asmacure Ltée
11.10.1 Asmacure Ltée Company Detail
11.10.2 Asmacure Ltée Business Overview
11.10.3 Asmacure Ltée Chronic Lung Diseases Treatment Introduction
11.10.4 Asmacure Ltée Revenue in Chronic Lung Diseases Treatment Business (2019-2024)
11.10.5 Asmacure Ltée Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Chronic Lung Diseases Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Injection
Table 3. Key Players of Capsule
Table 4. Key Players of Tablet
Table 5. Key Players of Other
Table 6. Global Chronic Lung Diseases Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Chronic Lung Diseases Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Chronic Lung Diseases Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Chronic Lung Diseases Treatment Market Share by Region (2019-2024)
Table 10. Global Chronic Lung Diseases Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Chronic Lung Diseases Treatment Market Share by Region (2025-2030)
Table 12. Chronic Lung Diseases Treatment Market Trends
Table 13. Chronic Lung Diseases Treatment Market Drivers
Table 14. Chronic Lung Diseases Treatment Market Challenges
Table 15. Chronic Lung Diseases Treatment Market Restraints
Table 16. Global Chronic Lung Diseases Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Chronic Lung Diseases Treatment Market Share by Players (2019-2024)
Table 18. Global Top Chronic Lung Diseases Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Lung Diseases Treatment as of 2023)
Table 19. Ranking of Global Top Chronic Lung Diseases Treatment Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Chronic Lung Diseases Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Chronic Lung Diseases Treatment Product Solution and Service
Table 23. Date of Enter into Chronic Lung Diseases Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Chronic Lung Diseases Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Chronic Lung Diseases Treatment Revenue Market Share by Type (2019-2024)
Table 27. Global Chronic Lung Diseases Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Chronic Lung Diseases Treatment Revenue Market Share by Type (2025-2030)
Table 29. Global Chronic Lung Diseases Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Chronic Lung Diseases Treatment Revenue Market Share by Application (2019-2024)
Table 31. Global Chronic Lung Diseases Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Chronic Lung Diseases Treatment Revenue Market Share by Application (2025-2030)
Table 33. North America Chronic Lung Diseases Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Chronic Lung Diseases Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Chronic Lung Diseases Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Chronic Lung Diseases Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Chronic Lung Diseases Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Chronic Lung Diseases Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Chronic Lung Diseases Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Chronic Lung Diseases Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Chronic Lung Diseases Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Chronic Lung Diseases Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Chronic Lung Diseases Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Chronic Lung Diseases Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Chronic Lung Diseases Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Chronic Lung Diseases Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Chronic Lung Diseases Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 48. Boehringer Ingelheim Company Detail
Table 49. Boehringer Ingelheim Business Overview
Table 50. Boehringer Ingelheim Chronic Lung Diseases Treatment Product
Table 51. Boehringer Ingelheim Revenue in Chronic Lung Diseases Treatment Business (2019-2024) & (US$ Million)
Table 52. Boehringer Ingelheim Recent Development
Table 53. Novartis Company Detail
Table 54. Novartis Business Overview
Table 55. Novartis Chronic Lung Diseases Treatment Product
Table 56. Novartis Revenue in Chronic Lung Diseases Treatment Business (2019-2024) & (US$ Million)
Table 57. Novartis Recent Development
Table 58. Roche Company Detail
Table 59. Roche Business Overview
Table 60. Roche Chronic Lung Diseases Treatment Product
Table 61. Roche Revenue in Chronic Lung Diseases Treatment Business (2019-2024) & (US$ Million)
Table 62. Roche Recent Development
Table 63. Astellas Pharma Company Detail
Table 64. Astellas Pharma Business Overview
Table 65. Astellas Pharma Chronic Lung Diseases Treatment Product
Table 66. Astellas Pharma Revenue in Chronic Lung Diseases Treatment Business (2019-2024) & (US$ Million)
Table 67. Astellas Pharma Recent Development
Table 68. Dr. Reddy’s Laboratories Company Detail
Table 69. Dr. Reddy’s Laboratories Business Overview
Table 70. Dr. Reddy’s Laboratories Chronic Lung Diseases Treatment Product
Table 71. Dr. Reddy’s Laboratories Revenue in Chronic Lung Diseases Treatment Business (2019-2024) & (US$ Million)
Table 72. Dr. Reddy’s Laboratories Recent Development
Table 73. GlaxoSmithKline Company Detail
Table 74. GlaxoSmithKline Business Overview
Table 75. GlaxoSmithKline Chronic Lung Diseases Treatment Product
Table 76. GlaxoSmithKline Revenue in Chronic Lung Diseases Treatment Business (2019-2024) & (US$ Million)
Table 77. GlaxoSmithKline Recent Development
Table 78. AstraZeneca Company Detail
Table 79. AstraZeneca Business Overview
Table 80. AstraZeneca Chronic Lung Diseases Treatment Product
Table 81. AstraZeneca Revenue in Chronic Lung Diseases Treatment Business (2019-2024) & (US$ Million)
Table 82. AstraZeneca Recent Development
Table 83. Sanofi Company Detail
Table 84. Sanofi Business Overview
Table 85. Sanofi Chronic Lung Diseases Treatment Product
Table 86. Sanofi Revenue in Chronic Lung Diseases Treatment Business (2019-2024) & (US$ Million)
Table 87. Sanofi Recent Development
Table 88. Teva Pharmaceuticals Company Detail
Table 89. Teva Pharmaceuticals Business Overview
Table 90. Teva Pharmaceuticals Chronic Lung Diseases Treatment Product
Table 91. Teva Pharmaceuticals Revenue in Chronic Lung Diseases Treatment Business (2019-2024) & (US$ Million)
Table 92. Teva Pharmaceuticals Recent Development
Table 93. Asmacure Ltée Company Detail
Table 94. Asmacure Ltée Business Overview
Table 95. Asmacure Ltée Chronic Lung Diseases Treatment Product
Table 96. Asmacure Ltée Revenue in Chronic Lung Diseases Treatment Business (2019-2024) & (US$ Million)
Table 97. Asmacure Ltée Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chronic Lung Diseases Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Chronic Lung Diseases Treatment Market Share by Type: 2023 VS 2030
Figure 3. Injection Features
Figure 4. Capsule Features
Figure 5. Tablet Features
Figure 6. Other Features
Figure 7. Global Chronic Lung Diseases Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Chronic Lung Diseases Treatment Market Share by Application: 2023 VS 2030
Figure 9. Bronchopulmonary Dysplasia Case Studies
Figure 10. Asthma Case Studies
Figure 11. COPD Case Studies
Figure 12. Pulmonary Fibrosis Case Studies
Figure 13. Chronic Lung Diseases Treatment Report Years Considered
Figure 14. Global Chronic Lung Diseases Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Chronic Lung Diseases Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Chronic Lung Diseases Treatment Market Share by Region: 2023 VS 2030
Figure 17. Global Chronic Lung Diseases Treatment Market Share by Players in 2023
Figure 18. Global Top Chronic Lung Diseases Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Lung Diseases Treatment as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Chronic Lung Diseases Treatment Revenue in 2023
Figure 20. North America Chronic Lung Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Chronic Lung Diseases Treatment Market Share by Country (2019-2030)
Figure 22. United States Chronic Lung Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Chronic Lung Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Chronic Lung Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Chronic Lung Diseases Treatment Market Share by Country (2019-2030)
Figure 26. Germany Chronic Lung Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Chronic Lung Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Chronic Lung Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Chronic Lung Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Chronic Lung Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Chronic Lung Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Chronic Lung Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Chronic Lung Diseases Treatment Market Share by Region (2019-2030)
Figure 34. China Chronic Lung Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Chronic Lung Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Chronic Lung Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Chronic Lung Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Chronic Lung Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Chronic Lung Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Chronic Lung Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Chronic Lung Diseases Treatment Market Share by Country (2019-2030)
Figure 42. Mexico Chronic Lung Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Chronic Lung Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Chronic Lung Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Chronic Lung Diseases Treatment Market Share by Country (2019-2030)
Figure 46. Turkey Chronic Lung Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Chronic Lung Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Boehringer Ingelheim Revenue Growth Rate in Chronic Lung Diseases Treatment Business (2019-2024)
Figure 49. Novartis Revenue Growth Rate in Chronic Lung Diseases Treatment Business (2019-2024)
Figure 50. Roche Revenue Growth Rate in Chronic Lung Diseases Treatment Business (2019-2024)
Figure 51. Astellas Pharma Revenue Growth Rate in Chronic Lung Diseases Treatment Business (2019-2024)
Figure 52. Dr. Reddy’s Laboratories Revenue Growth Rate in Chronic Lung Diseases Treatment Business (2019-2024)
Figure 53. GlaxoSmithKline Revenue Growth Rate in Chronic Lung Diseases Treatment Business (2019-2024)
Figure 54. AstraZeneca Revenue Growth Rate in Chronic Lung Diseases Treatment Business (2019-2024)
Figure 55. Sanofi Revenue Growth Rate in Chronic Lung Diseases Treatment Business (2019-2024)
Figure 56. Teva Pharmaceuticals Revenue Growth Rate in Chronic Lung Diseases Treatment Business (2019-2024)
Figure 57. Asmacure Ltée Revenue Growth Rate in Chronic Lung Diseases Treatment Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Table 1. Global Chronic Lung Diseases Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Injection
Table 3. Key Players of Capsule
Table 4. Key Players of Tablet
Table 5. Key Players of Other
Table 6. Global Chronic Lung Diseases Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Chronic Lung Diseases Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Chronic Lung Diseases Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Chronic Lung Diseases Treatment Market Share by Region (2019-2024)
Table 10. Global Chronic Lung Diseases Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Chronic Lung Diseases Treatment Market Share by Region (2025-2030)
Table 12. Chronic Lung Diseases Treatment Market Trends
Table 13. Chronic Lung Diseases Treatment Market Drivers
Table 14. Chronic Lung Diseases Treatment Market Challenges
Table 15. Chronic Lung Diseases Treatment Market Restraints
Table 16. Global Chronic Lung Diseases Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Chronic Lung Diseases Treatment Market Share by Players (2019-2024)
Table 18. Global Top Chronic Lung Diseases Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Lung Diseases Treatment as of 2023)
Table 19. Ranking of Global Top Chronic Lung Diseases Treatment Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Chronic Lung Diseases Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Chronic Lung Diseases Treatment Product Solution and Service
Table 23. Date of Enter into Chronic Lung Diseases Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Chronic Lung Diseases Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Chronic Lung Diseases Treatment Revenue Market Share by Type (2019-2024)
Table 27. Global Chronic Lung Diseases Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Chronic Lung Diseases Treatment Revenue Market Share by Type (2025-2030)
Table 29. Global Chronic Lung Diseases Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Chronic Lung Diseases Treatment Revenue Market Share by Application (2019-2024)
Table 31. Global Chronic Lung Diseases Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Chronic Lung Diseases Treatment Revenue Market Share by Application (2025-2030)
Table 33. North America Chronic Lung Diseases Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Chronic Lung Diseases Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Chronic Lung Diseases Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Chronic Lung Diseases Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Chronic Lung Diseases Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Chronic Lung Diseases Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Chronic Lung Diseases Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Chronic Lung Diseases Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Chronic Lung Diseases Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Chronic Lung Diseases Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Chronic Lung Diseases Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Chronic Lung Diseases Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Chronic Lung Diseases Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Chronic Lung Diseases Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Chronic Lung Diseases Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 48. Boehringer Ingelheim Company Detail
Table 49. Boehringer Ingelheim Business Overview
Table 50. Boehringer Ingelheim Chronic Lung Diseases Treatment Product
Table 51. Boehringer Ingelheim Revenue in Chronic Lung Diseases Treatment Business (2019-2024) & (US$ Million)
Table 52. Boehringer Ingelheim Recent Development
Table 53. Novartis Company Detail
Table 54. Novartis Business Overview
Table 55. Novartis Chronic Lung Diseases Treatment Product
Table 56. Novartis Revenue in Chronic Lung Diseases Treatment Business (2019-2024) & (US$ Million)
Table 57. Novartis Recent Development
Table 58. Roche Company Detail
Table 59. Roche Business Overview
Table 60. Roche Chronic Lung Diseases Treatment Product
Table 61. Roche Revenue in Chronic Lung Diseases Treatment Business (2019-2024) & (US$ Million)
Table 62. Roche Recent Development
Table 63. Astellas Pharma Company Detail
Table 64. Astellas Pharma Business Overview
Table 65. Astellas Pharma Chronic Lung Diseases Treatment Product
Table 66. Astellas Pharma Revenue in Chronic Lung Diseases Treatment Business (2019-2024) & (US$ Million)
Table 67. Astellas Pharma Recent Development
Table 68. Dr. Reddy’s Laboratories Company Detail
Table 69. Dr. Reddy’s Laboratories Business Overview
Table 70. Dr. Reddy’s Laboratories Chronic Lung Diseases Treatment Product
Table 71. Dr. Reddy’s Laboratories Revenue in Chronic Lung Diseases Treatment Business (2019-2024) & (US$ Million)
Table 72. Dr. Reddy’s Laboratories Recent Development
Table 73. GlaxoSmithKline Company Detail
Table 74. GlaxoSmithKline Business Overview
Table 75. GlaxoSmithKline Chronic Lung Diseases Treatment Product
Table 76. GlaxoSmithKline Revenue in Chronic Lung Diseases Treatment Business (2019-2024) & (US$ Million)
Table 77. GlaxoSmithKline Recent Development
Table 78. AstraZeneca Company Detail
Table 79. AstraZeneca Business Overview
Table 80. AstraZeneca Chronic Lung Diseases Treatment Product
Table 81. AstraZeneca Revenue in Chronic Lung Diseases Treatment Business (2019-2024) & (US$ Million)
Table 82. AstraZeneca Recent Development
Table 83. Sanofi Company Detail
Table 84. Sanofi Business Overview
Table 85. Sanofi Chronic Lung Diseases Treatment Product
Table 86. Sanofi Revenue in Chronic Lung Diseases Treatment Business (2019-2024) & (US$ Million)
Table 87. Sanofi Recent Development
Table 88. Teva Pharmaceuticals Company Detail
Table 89. Teva Pharmaceuticals Business Overview
Table 90. Teva Pharmaceuticals Chronic Lung Diseases Treatment Product
Table 91. Teva Pharmaceuticals Revenue in Chronic Lung Diseases Treatment Business (2019-2024) & (US$ Million)
Table 92. Teva Pharmaceuticals Recent Development
Table 93. Asmacure Ltée Company Detail
Table 94. Asmacure Ltée Business Overview
Table 95. Asmacure Ltée Chronic Lung Diseases Treatment Product
Table 96. Asmacure Ltée Revenue in Chronic Lung Diseases Treatment Business (2019-2024) & (US$ Million)
Table 97. Asmacure Ltée Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chronic Lung Diseases Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Chronic Lung Diseases Treatment Market Share by Type: 2023 VS 2030
Figure 3. Injection Features
Figure 4. Capsule Features
Figure 5. Tablet Features
Figure 6. Other Features
Figure 7. Global Chronic Lung Diseases Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Chronic Lung Diseases Treatment Market Share by Application: 2023 VS 2030
Figure 9. Bronchopulmonary Dysplasia Case Studies
Figure 10. Asthma Case Studies
Figure 11. COPD Case Studies
Figure 12. Pulmonary Fibrosis Case Studies
Figure 13. Chronic Lung Diseases Treatment Report Years Considered
Figure 14. Global Chronic Lung Diseases Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Chronic Lung Diseases Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Chronic Lung Diseases Treatment Market Share by Region: 2023 VS 2030
Figure 17. Global Chronic Lung Diseases Treatment Market Share by Players in 2023
Figure 18. Global Top Chronic Lung Diseases Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Lung Diseases Treatment as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Chronic Lung Diseases Treatment Revenue in 2023
Figure 20. North America Chronic Lung Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Chronic Lung Diseases Treatment Market Share by Country (2019-2030)
Figure 22. United States Chronic Lung Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Chronic Lung Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Chronic Lung Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Chronic Lung Diseases Treatment Market Share by Country (2019-2030)
Figure 26. Germany Chronic Lung Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Chronic Lung Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Chronic Lung Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Chronic Lung Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Chronic Lung Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Chronic Lung Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Chronic Lung Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Chronic Lung Diseases Treatment Market Share by Region (2019-2030)
Figure 34. China Chronic Lung Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Chronic Lung Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Chronic Lung Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Chronic Lung Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Chronic Lung Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Chronic Lung Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Chronic Lung Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Chronic Lung Diseases Treatment Market Share by Country (2019-2030)
Figure 42. Mexico Chronic Lung Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Chronic Lung Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Chronic Lung Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Chronic Lung Diseases Treatment Market Share by Country (2019-2030)
Figure 46. Turkey Chronic Lung Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Chronic Lung Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Boehringer Ingelheim Revenue Growth Rate in Chronic Lung Diseases Treatment Business (2019-2024)
Figure 49. Novartis Revenue Growth Rate in Chronic Lung Diseases Treatment Business (2019-2024)
Figure 50. Roche Revenue Growth Rate in Chronic Lung Diseases Treatment Business (2019-2024)
Figure 51. Astellas Pharma Revenue Growth Rate in Chronic Lung Diseases Treatment Business (2019-2024)
Figure 52. Dr. Reddy’s Laboratories Revenue Growth Rate in Chronic Lung Diseases Treatment Business (2019-2024)
Figure 53. GlaxoSmithKline Revenue Growth Rate in Chronic Lung Diseases Treatment Business (2019-2024)
Figure 54. AstraZeneca Revenue Growth Rate in Chronic Lung Diseases Treatment Business (2019-2024)
Figure 55. Sanofi Revenue Growth Rate in Chronic Lung Diseases Treatment Business (2019-2024)
Figure 56. Teva Pharmaceuticals Revenue Growth Rate in Chronic Lung Diseases Treatment Business (2019-2024)
Figure 57. Asmacure Ltée Revenue Growth Rate in Chronic Lung Diseases Treatment Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Paint Leveling Agent Market Insights, Forecast to 2030
Dec 22, 24
Global Paint Adhesion Promoters Market Insights, Forecast to 2030
Dec 22, 24
Global Paint Rheological Additives Market Insights, Forecast to 2030
Dec 22, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232